Core Viewpoint - Enwei Pharmaceutical (301331.SZ) announced a share transfer plan involving its major shareholder, Chengdu Enwei Investment (Group) Co., Ltd., which intends to transfer 4,000,000 shares, representing 3.89% of the total share capital [1] Group 1: Share Transfer Details - The total share capital of Enwei Pharmaceutical is 102,891,887 shares, with 1,055,326 shares held in a repurchase account [1] - The proposed transfer will not occur through centralized bidding or block trading, and the transferee will be institutional investors with appropriate pricing and risk-bearing capabilities [1] - The shares transferred will be restricted from being sold for six months after the transfer [1] Group 2: Shareholder Information - Chengdu Enwei Investment (Group) Co., Ltd. holds 13.45% of the company's shares after the transfer [2] - Based on the closing price of 30.51 yuan per share, the cash amount from this transfer is approximately 122 million yuan [2] - As of the announcement date, Chengdu Enwei Investment (Group) Co., Ltd. and its concerted parties have pledged 50,420,836 shares, accounting for 70.91% of their holdings and 49.00% of the total share capital [2]
恩威医药控股股东拟询价转让套现1.2亿 总股本49%质押